NI
CVS icon

Nepsis Inc’s CVS Health CVS Stock Holding History

Nepsis Inc’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-156,239
Closed -$14.9M – 31
2022
Q3 		$14.9M Buy
156,239
+2,873
+2% +$284K 5.39% 3
2022
Q2 		$14.2M Sell
153,366
-32,891
-18% -$3.21M 4.85% 6
2022
Q1 		$18.9M Sell
186,257
-11,291
-6% -$1.19M 5.63% 2
2021
Q4 		$20.4M Buy
197,548
+3,797
+2% +$351K 5.91% 3
2021
Q3 		$16.4M Buy
193,751
+27,253
+16% +$2.28M 5.18% 5
2021
Q2 		$13.9M Buy
166,498
+2,762
+2% +$226K 4.4% 8
2021
Q1 		$12.3M Buy
163,736
+51,597
+46% +$3.76M 3.9% 12
2020
Q4 		$7.66M Buy
112,139
+94,015
+519% +$6.11M 2.78% 20
2020
Q3 		$1.06M Sell
18,124
-897
-5% -$55.8K 0.51% 32
2020
Q2 		$1.24M Sell
19,021
-4,030
-17% -$254K 0.6% 28
2020
Q1 		$1.37M Sell
23,051
-91,477
-80% -$6.11M 0.91% 27
2019
Q4 		$8.43M Sell
114,528
-568
-0.5% -$39.9K 4.27% 6
2019
Q3 		$7.05M Buy
115,096
+6,878
+6% +$408K 4.06% 9
2019
Q2 		$5.9M Buy
+108,218
New +$5.83M 3.27% 14

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nepsis Inc's CVS Position: Q4 2022 in Review

Nepsis Inc sold out of CVS Health (CVS) in Q4 2022, closing a stake of 156,239 shares — an estimated $14.9M sold.

Nepsis Inc first reported a position in CVS in Q2 2019 and held it in 14 quarters. The position peaked at $20.4M in Q4 2021. 2,406 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • Nepsis Inc reported no remaining CVS Health position as of Q4 2022 after selling out during the quarter.
  • Nepsis Inc sold 156,239 CVS Health shares in Q4 2022, an estimated $14.9M.
  • Nepsis Inc first reported a position in CVS Health in Q2 2019 and held it in 14 quarters.
  • Nepsis Inc's CVS Health position peaked at $20.4M in Q4 2021.
  • 2,406 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Nepsis Inc's 13F filing for Q4 2022, filed 25 Jan 2023.